Do we need new high-risk criteria for surgically treated renal cancer patients to improve the outcome of future clinical trials in the adjuvant setting? Results of a comprehensive analysis based on the multicenter CORONA database

  1. Wolff, I.
  2. May, M.
  3. Hoschke, B.
  4. Zigeuner, R.
  5. Cindolo, L.
  6. Hutterer, G.
  7. Schips, L.
  8. De Cobelli, O.
  9. Rocco, B.
  10. De Nunzio, C.
  11. Tubaro, A.
  12. Coman, I.
  13. Feciche, B.
  14. Truss, M.
  15. Dalpiaz, O.
  16. Figenshau, R.S.
  17. Madison, K.
  18. Sánchez-Chapado, M.
  19. Santiago Martin, M.D.C.
  20. Salzano, L.
  21. Lotrecchiano, G.
  22. Shariat, S.F.
  23. Hohenfellner, M.
  24. Waidelich, R.
  25. Stief, C.
  26. Miller, K.
  27. Pahernik, S.
  28. Brookman-May, S.
  29. Erakutsi egile guztiak +
Aldizkaria:
European Journal of Surgical Oncology

ISSN: 1532-2157 0748-7983

Argitalpen urtea: 2016

Alea: 42

Zenbakia: 5

Orrialdeak: 744-750

Mota: Artikulua

DOI: 10.1016/J.EJSO.2016.01.009 GOOGLE SCHOLAR